Systemic therapy for advanced cholangiocarcinoma: divergences in global guidelines and regional clinical implementation
Cholangiocarcinoma (CCA) is a group of malignant tumors arising from the biliary epithelium, with systemic therapy serving as the primary treatment approach for patients with advanced disease. In recent years, advances in molecular classification and targeted therapy have led to rapid updates in tre...
Saved in:
| Main Author: | LI Chun, MA Zuyi, SUN Jia, LI Binglu |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Surgery Concepts & Practice
2025-03-01
|
| Series: | Waike lilun yu shijian |
| Subjects: | |
| Online Access: | https://www.qk.sjtu.edu.cn/jscp/fileup/1007-9610/PDF/1751876366055-475213852.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of local–regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study
by: Shuofeng Li, et al.
Published: (2025-05-01) -
Molecular and Pathological Heterogeneity of Synchronous Small and Large Duct Intrahepatic Cholangiocarcinoma—A Case Series
by: Savelina Popovska, et al.
Published: (2025-04-01) -
Analysis of risk factors of cholangiocarcinoma, role of diabetes mellitus and hepatitis B virus infection in the intrahepatic and extrahepatic cholangiocarcinoma: a retrospective case-based study in China
by: Hasan Md Rasadul, et al.
Published: (2025-07-01) -
Treating intrahepatic cholangiocarcinoma with pemigatinib: two case reports of Nordic patients
by: Vesa T. Väliaho, et al.
Published: (2025-04-01) -
Local–regional therapy combined with immune checkpoint inhibitors and lenvatinib versus immune checkpoint inhibitors plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter cohort study
by: Shuofeng Li, et al.
Published: (2025-07-01)